FDA backs Pfizer COVID-19 boosters for seniors, high-risk
The U.S. moved a step closer to offering booster doses of Pfizer's COVID-19 vaccine to senior citizens and others at high risk from the virus.
The U.S. moved a step closer to offering booster doses of Pfizer's COVID-19 vaccine to senior citizens and others at high risk from the virus.